.jpg)
STAT+: Flagship startup Laronde hopes to use ‘endless RNA’ to produce new treatments
In 2017, scientists at Flagship Pioneering were exploring different kinds of ribonucleic acid, or RNA, focusing on an unusual form of the molecule that had a circular shape, rather than a linear strand with two ends.
“When I saw that, I got excited,” said Avak Kahvejian, a general partner at the Cambridge venture capital firm. “I thought it was a way the cell was making really robust, stable RNAs, which are usually very unstable.”
